Sai Parenteral's IPO
Sai Parenteral's IPO
Total Shares
1,04,28,288
Issue Size
₹409 Cr
Price Band
₹372 – ₹392
Lot Size
38 shares
Min. Investment
₹14,896
Max. Investment
₹1,93,648
Open Date
24 Mar, 2026
Close Date
27 Mar, 2026
Allotment
30 Mar, 2026
Listing
02 Apr, 2026
Max. Investment
₹1,93,648
Announced
24 Mar, 2026
Opening Date
24 Mar, 2026
Closing Date
27 Mar, 2026
Basis of Allotment
30 Mar, 2026
Initiation of Refunds
01 Apr, 2026
Credit of Shares
01 Apr, 2026
Listing Date
02 Apr, 2026
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Sai Parenteral's IPO
Incorporated in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing.
The company operates in two segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services for domestic and international markets.
The product portfolio spans multiple therapeutic areas including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, ant
Sai Parenteral's IPO Share Price
Issue Breakdown
Shareholding
Dilution: 19.7% increase in shares
Sai Parenteral's IPO Financial Health
Sai Parenteral's IPO Lot Size
Investors can bid for a minimum of 38 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | ₹14,896 |
| Retail (Max) | 13 | 494 | ₹1,93,648 |
| S-HNI (Min) | 14 | 532 | ₹2,08,544 |
| S-HNI (Max) | 67 | 2546 | ₹9,98,032 |
| B-HNI (Min) | 68 | 2584 | ₹10,12,928 |
(All values in CR)
Sai Parenteral's IPO Valuations
| Metric | Value |
|---|---|
| ROE | 5.13 |
| ROCE | 9.28 |
| RoNW | 5.09 |
| PAT Margin | 8.93 |
| EBITDA Margin | 18.68 |
| Price to Book Value | - |
(All values in CR)
Sai Parenteral's IPO Strength & Risk
Sai Parenteral's IPO Strengths 👍
Operates in the pharmaceutical sector with focus on injectable and parenteral formulations
Specialized manufacturing capabilities in sterile injectables with high entry barriers
Growing demand for injectable medicines in hospitals and healthcare institutions
Strong quality standards and compliance with regulatory requirements
Established relationships with hospitals, distributors, and healthcare providers
Potential for export growth in regulated and semi-regulated markets
Experienced management team with industry expertise
Sai Parenteral's IPO Risks ⚠️
Highly regulated industry with strict compliance and approval requirements
Dependence on a limited number of products or therapeutic segments
High capital expenditure required for maintaining sterile manufacturing facilities
Pricing pressure due to competition and government regulations
Exposure to raw material price fluctuations and supply chain disruptions
Risk of regulatory actions, product recalls, or quality issues
Intense competition from established pharmaceutical companies
Sai Parenteral's IPO Subscriptions Status
Sai Parenteral's IPO subscribed 0.46 times. The public issue subscribed 0.08 times in the retail category, 0.60 times in QIB (Ex Anchor), and 1.14 times in the NII category by March 27, 2026 11:49:38 AM (Day 3).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 31,28,485 | 31,28,485 | 122.637 |
| QIB (Ex Anchor) | 0.60 | 20,85,659 | 12,60,574 | 49.415 |
| NII | 1.05 | 15,64,243 | 17,80,756 | 69.806 |
| bNII (> ₹10L) | 1.55 | 10,42,829 | 17,37,208 | 68.099 |
| sNII (< ₹10L) | 0.04 | 5,21,414 | 43,548 | 1.707 |
| Retail | 0.05 | 36,49,901 | 2,87,546 | 11.272 |
| Total | 0.42 | 72,99,803 | 33,28,876 | 130.492 |
Sai Parenteral's IPO GMP
Sai Parenteral's IPO last GMP is ₹0, last updated Mar 27th 2026 11:31 AM. With the price band of 392.00, Sai Parenteral's IPO's estimated listing price is ₹392 (cap price + today's GMP).The expected percentage gain/loss per share is 0.00%.
Last updated 27 Mar, 2026 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 27 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 27 Mar, 2026 |
| 26 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 26 Mar, 2026 |
| 25 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 25 Mar, 2026 |
| 24 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 24 Mar, 2026 |
| 23 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 23 Mar, 2026 |
| 22 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 22 Mar, 2026 |
| 21 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 21 Mar, 2026 |
| 20 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 20 Mar, 2026 |
| 19 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 19 Mar, 2026 |
| 18 Mar, 2026 | 392 | ₹0 | - | ₹392 (0.00%) | - | 18 Mar, 2026 |
| 17 Mar, 2026 | 0 | ₹0 | - | ₹ (%) | - | 17 Mar, 2026 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Sai Parenteral's IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Sai Parenteral's IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.